Skip to main content

Home

2021 Virtual Experience
Where Debate & Discussion Translate to Better Treatments
2 Dates Remaining!

Join us for a unique educational experience. In this debate-style series, nationally recognized thought leaders take opposing sides on clinical, and sometimes controversial, topics currently disrupting the practice of hematology/oncology.   

Through a comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.

Interactive Format. Practical Implications.

The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, such as multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, lymphoma, and so much more.

 

 

9
Scientific Sessions
15.5
CME Credits
24
Expert Faculty
6
Months of On-Demand Access
Heading
Who Should Attend?
Body

These live educational activities are designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, and myeloid malignancies.

List
Hematologists
Medical Oncologists
Physicians
Physician Assistants
Physicians-in-Training
Oncology Nurses
Pharmacists
speakers
Heading
Featured Topics
Body

As an event best known for its unique, debate-style format, the 2021 agenda features a mix of didactic lectures and debates, examining the latest and most controversial topics across the board in the field of hematologic malignancies. 

List
Multiple Myeloma
Acute Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Chronic Myeloid Leukemia
Myelodysplastic Syndrome
Myeloproliferative Neoplasms
Special Topics in Hematologic Malignancies
Meet the Chairs
Jessica K. Altman, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois
John P. Leonard, MD
Center for Lymphoma and Myeloma
Weill Cornell Medicine
New York, New York
Joseph R. Mikhael, MD, MEd, FRCPC
Translational Genomics Research Institute (TGen)
City of Hope Cancer Center
Phoenix, Arizona
Endorsers

Keep Me Informed